Total Payments
$789.22
2024 Payments
$57.07
Companies
16
Transactions
40
Medicare Patients
1,374
Medicare Billing
$231,433
Payment Breakdown by Category
Food & Beverage$762.67 (96.6%)
Education$26.55 (3.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $762.67 | 38 | 96.6% |
| Education | $26.55 | 2 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $269.55 | 13 | $0 (2024) |
| Janssen Biotech, Inc. | $115.88 | 5 | $0 (2023) |
| GlaxoSmithKline, LLC. | $73.18 | 5 | $0 (2021) |
| PFIZER INC. | $66.47 | 4 | $0 (2019) |
| JAZZ PHARMACEUTICALS INC. | $50.00 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $34.27 | 2 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $31.53 | 1 | $0 (2023) |
| Genentech USA, Inc. | $20.61 | 1 | $0 (2019) |
| Celgene Corporation | $20.07 | 1 | $0 (2022) |
| Coherus Biosciences Inc. | $17.67 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $57.07 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($23.46) |
| 2023 | $159.22 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($87.11) |
| 2022 | $20.07 | 1 | Celgene Corporation ($20.07) |
| 2021 | $174.38 | 12 | Takeda Pharmaceuticals U.S.A., Inc. ($119.21) |
| 2020 | $47.43 | 3 | GlaxoSmithKline, LLC. ($29.93) |
| 2019 | $176.57 | 7 | Janssen Biotech, Inc. ($72.30) |
| 2018 | $154.48 | 8 | PFIZER INC. ($50.81) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/18/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 04/18/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: ONCOLOGY | ||||||
| 02/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/26/2023 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: ONCOLOGY | ||||||
| 10/04/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $31.53 | General |
| Category: Gastroenterology | ||||||
| 09/12/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/04/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/22/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/01/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Oncology | ||||||
| 12/14/2022 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $20.07 | General |
| Category: Hematology | ||||||
| 11/02/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/02/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $1.16 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/14/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/10/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/10/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $2.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/30/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/07/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: RESPIRATORY | ||||||
| 06/22/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/22/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $1.84 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 04/23/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: RESPIRATORY | ||||||
| 01/20/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: RESPIRATORY | ||||||
| 11/23/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: RESPIRATORY | ||||||
| 05/28/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.50 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 291 | 452 | $79,037 | $29,113 |
| 2022 | 3 | 345 | 851 | $161,912 | $63,396 |
| 2021 | 5 | 371 | 884 | $167,321 | $68,220 |
| 2020 | 4 | 367 | 1,116 | $209,638 | $70,704 |
Total Patients
1,374
Total Services
3,303
Medicare Billing
$231,433
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 146 | 230 | $43,700 | $16,424 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 128 | 205 | $30,730 | $10,905 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 17 | $4,607 | $1,785 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 307 | 813 | $151,870 | $59,895 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 22 | $5,786 | $2,078 | 35.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $4,256 | $1,422 | 33.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 292 | 799 | $143,820 | $59,596 | 41.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 31 | $8,153 | $3,375 | 41.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $7,619 | $2,678 | 35.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 18 | 18 | $4,788 | $1,645 | 34.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 17 | $2,941 | $926.09 | 31.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 300 | 1,048 | $188,640 | $63,585 | 33.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 22 | 22 | $8,822 | $3,022 | 34.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 26 | 26 | $6,916 | $2,310 | 33.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 19 | 20 | $5,260 | $1,787 | 34.0% |
About Dr. Amir Khan, M.D
Dr. Amir Khan, M.D is a Hematology & Oncology healthcare provider based in Lynchburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609944586.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amir Khan, M.D has received a total of $789.22 in payments from pharmaceutical and medical device companies, with $57.07 received in 2024. These payments were reported across 40 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($762.67).
As a Medicare-enrolled provider, Khan has provided services to 1,374 Medicare beneficiaries, totaling 3,303 services with total Medicare billing of $231,433. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Lynchburg, VA
- Active Since 12/01/2006
- Last Updated 04/05/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1609944586
Products in Payments
- MOTEGRITY (Drug) $119.21
- ENTYVIO (Biological) $110.57
- ANORO ELLIPTA (Drug) $73.18
- DARZALEX (Biological) $56.86
- VYXEOS (Drug) $50.00
- Amitiza (Drug) $39.77
- Erleada (Drug) $34.38
- XARELTO (Drug) $34.27
- XIFAXAN (Drug) $31.53
- ERLEADA (Drug) $24.64
- Perjeta (Biological) $20.61
- REBLOZYL (Biological) $20.07
- BOSULIF (Drug) $19.68
- Udenyca (Biological) $17.67
- OPDIVO (Biological) $17.50
- MYLOTARG (Biological) $16.50
- CINQAIR (Drug) $16.13
- VENCLEXTA (Drug) $15.94
- XALKORI (Drug) $15.94
- BESPONSA (Biological) $15.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Lynchburg
Nicholette Erickson, Md, MD
Hematology & Oncology — Payments: $6,385
Hematology & Oncology $6,385
Dr. Jong An, Do, DO
Hematology & Oncology — Payments: $6,362
Hematology & Oncology $6,362
Dr. Emaculate Tebit, M.d, M.D
Hematology & Oncology — Payments: $29.86
Hematology & Oncology $29.86
Dr. Mahmood Rasheed, M.d, M.D
Hematology & Oncology — Payments: $25.52
Hematology & Oncology $25.52
Pooja Mehra
Hematology & Oncology
Hematology & Oncology